These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5865871)

  • 21. Effects of promazine and chlorpromazine metabolites on the cornea.
    Adams HR; Manian AA; Steenberg ML; Buckley JP
    Adv Biochem Psychopharmacol; 1974; 9(0):281-93. PubMed ID: 4836207
    [No Abstract]   [Full Text] [Related]  

  • 22. [Significance of the binding of drugs to albumin and erythrocytes in a perfusion medium for the isolated rat liver].
    Jähnchen E; Krieglstein J; Kunkel F; Samuelis WJ; Wollert U
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(1):67-84. PubMed ID: 4252444
    [No Abstract]   [Full Text] [Related]  

  • 23. The metabolism of chlorpromazine and promethazine to give new 'pink spots'.
    Beckett AH; Al-Sarraj S; Essien EE
    Xenobiotica; 1975 Jun; 5(6):325-55. PubMed ID: 1146356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inter-patient variation in chlorpromazine metabolism.
    Green DE; Forrest IS; Forrest FM; Serra MT
    Exp Med Surg; 1965; 23(2):278-87. PubMed ID: 5843918
    [No Abstract]   [Full Text] [Related]  

  • 25. Model metabolites of chlorpromazine and promazine: relative activities in some pharmacological and behavioral tests.
    POSNER HS; HEARST E; TAYLOR WL; COSMIDES GJ
    J Pharmacol Exp Ther; 1962 Jul; 137():84-90. PubMed ID: 14488181
    [No Abstract]   [Full Text] [Related]  

  • 26. Kinetic evaluation of the oxidation of phenothiazine derivatives by methemoglobin and horseradish peroxidase in the presence of hydrogen peroxide. Implications for the reaction mechanisms.
    Kelder PP; de Mol NJ; Fischer MJ; Janssen LH
    Biochim Biophys Acta; 1994 Apr; 1205(2):230-8. PubMed ID: 8155702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultraviolet and attenuated total reflectance infrared spectra of chlorpromazine metabolites.
    Warren RJ; Thompson WE; Zarembo JE; Eisdorfer IB
    J Pharm Sci; 1967 Nov; 56(11):1496-500. PubMed ID: 6060595
    [No Abstract]   [Full Text] [Related]  

  • 28. The sulfoxides as an additional rapid test for phenothiazine tranquilizers.
    Korczak-Fabierkiewicz C; Kofoed J; Lucas GH
    J Forensic Sci; 1965 Jul; 10(3):308-12. PubMed ID: 5854840
    [No Abstract]   [Full Text] [Related]  

  • 29. PHENOTHIAZINE DERIVATIVES.
    DELGADO JN; COSGROVE FP; ISAACSON EI
    Tex State J Med; 1964 Mar; 60():315-8. PubMed ID: 14131729
    [No Abstract]   [Full Text] [Related]  

  • 30. The metabolism of hydroxychlorpromazines by rat liver microsomes.
    Daly JW; Manian AA
    Biochem Pharmacol; 1967 Nov; 16(11):2131-6. PubMed ID: 4383838
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantitative determination of chlorpromazine metabolites in urine.
    Turner WJ; Turano PA; March JE
    Clin Chem; 1970 Nov; 16(11):916-21. PubMed ID: 5473553
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats.
    Kodavanti UP; Lockard VG; Mehendale HM
    J Biochem Toxicol; 1990; 5(4):245-51. PubMed ID: 1965728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of flavin-adenine dinucleotide-requiring enzymes and phenothiazines. II. Structural requirements for D-amino acid oxidase inhibition.
    Gabay S; Harris SR
    Biochem Pharmacol; 1966 Mar; 15(3):317-22. PubMed ID: 4380375
    [No Abstract]   [Full Text] [Related]  

  • 34. Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.
    Curry SH; Whelpton R; de Schepper PJ; Vranckx S; Schiff AA
    Br J Clin Pharmacol; 1979 Apr; 7(4):325-31. PubMed ID: 444352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid in vitro sulfoxidation of chlorpromazine by human blood: inhibition by an endogenous plasma protein factor.
    Traficante LJ; Sakalis G; Siekierski J; Rotrosen J; Gershon S
    Life Sci; 1979 Jan; 24(4):337-45. PubMed ID: 431325
    [No Abstract]   [Full Text] [Related]  

  • 36. A polarographic method for the determination of the N-oxide, N-oxide-sulphoxide and sulphoxide metabolites of chlorpromazine.
    Beckett AH; Essien EE; Smyth WF
    J Pharm Pharmacol; 1974 Jun; 26(6):399-407. PubMed ID: 4154983
    [No Abstract]   [Full Text] [Related]  

  • 37. Methods for study of fluphenazine kinetics in man.
    Whelpton R; Curry SH
    J Pharm Pharmacol; 1976 Dec; 28(12):869-73. PubMed ID: 12260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative distribution, excretion, and metabolism of 14C-labeled quaternary ammonium compounds of promazine, chlorpromazine, and triflupromazine.
    Huang CL; Yeh JZ; Muni IA
    J Pharm Sci; 1970 Aug; 59(8):1114-8. PubMed ID: 5457327
    [No Abstract]   [Full Text] [Related]  

  • 39. Reaction of cationic groups of chlorpromazine with anionic macromolecules: complexes with DNA, RNA, hyaluronic acid and heparin.
    Blumenkrantz N; Asboe-Hansen G
    Acta Pharmacol Toxicol (Copenh); 1974 Jan; 34(1):27-32. PubMed ID: 4406557
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the urinary excretion of various phenothiazines in subjects afflicted respectively with a depressive state and a state of manic excitement].
    CITTERIO C
    Rass Neuropsichiatr; 1961; 15():238-41. PubMed ID: 13879616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.